Atheronova Inc.

Atheronova Inc.
Stock Exchange Other OTC
EPS
-
Market Cap
$83.69 K
Shares Outstanding
8.81 M
Public Float
2.58 M

Profile

Address
2301 Dupont Drive
Irvine California 92612
United States
Employees -
Website -
Updated 07/08/2019
AtheroNova, Inc. is a biotechnology company. The company engages in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. It develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, which is the primary cause of various cardiovascular diseases.

Financials

View All

Randolph M. Johnson
Chief Operating Officer